Inhalytix®+

Contact Us

Contact Us

Inhalytix®+

The Complete Platform for APSD Data Management

Inhalytix+ was developed in direct response to the challenges faced by analysts, scientists, and quality teams working with orally inhaled and nasal drug products (OINDPs). Manual workflows, isolated spreadsheets, and disconnected equipment introduce unnecessary complexity and risk. Inhalytix+ changes that by providing a single, connected platform that supports consistent data capture, traceability, and regulatory readiness.

Key Highlights:

  • Centralised APSD workflow from method to report
  • Integrated metadata, test parameters, and equipment records
  • Improved lab efficiency and reduced potential for human error
  • Support for GMP and 21 CFR Part 11 compliance
  • Scalable platform designed for future integration
View Inhalytix®+ Brochure

See Inhalytix®+ in Action

Play Video

Centralised Control for APSD Data Analysis

One Platform, Complete Oversight

Inhalytix®+ brings together all critical elements of APSD data management into one connected system. Test methods, user activity, equipment details and analytical results are captured and stored in a structured, central environment.

This centralised approach ensures greater visibility, consistent data handling and easier access to the information that matters. Whether managing workflows, ensuring traceability or supporting compliance, Inhalytix+ helps streamline operations across the entire testing process.

Inhalytix+ data flow

Designed to Simplify Complex Testing Workflows

Unified APSD Workflow
Bring method setup, equipment connectivity, test execution, and results reporting into one connected platform. Inhalytix+ simplifies the entire APSD process by reducing manual handoffs and enabling a consistent, structured approach.

Instant, Reliable Results
Automated data transfer from connected equipment eliminates the need for manual entry and reduces the risk of error – allowing faster, more accurate metric calculations.

Built-In Data Integrity Controls
Every result is verified through integrated validation and structured compliance features, helping ensure accuracy and meet regulatory standards.

Full Traceability
All test results are automatically linked to the method, equipment configuration, and operator responsible. This creates a clear, audit-ready record for every test.

Simple, All-Inclusive Subscription

Inhalytix®+ is offered as an all-inclusive subscription that provides everything your lab needs for efficient and compliant APSD testing.

Your subscription includes:

✔ Unlimited test run analyses
✔ Continuous updates to maintain compliance and add new features
✔ Built-in audit trails for complete traceability
✔ Customisable methods and reporting capabilities
✔ Comprehensive technical support
✔ Optional user training packages to help your team get up to speed

View Inhalytix®+ Brochure Request a Personalised Demo

Software Updates

We have recently released a new version of Inhalytix. To check if your software version is out of date and may be missing critical updates and bug fixes, please contact support@copleyscientific.co.uk to ensure your data integrity and discuss updating to the latest version as soon as possible.

Notification of Withdrawal of Support for CITDAS

Formal notification of the withdrawal of technical support for all versions and releases of CITDAS was effective 30th November 2023.  This means, Copley will no longer provide help for bug fixes, error messages, custom work or any other issues. Copley launched the Inhalytix software application in 2021 which effectively superseded CITDAS.  Inhalytix provides the capabilities of CITDAS alongside other advanced features, and has been verified to provide the same APSD metrics when the same raw data is input into both applications.